Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > GL All

<< Previous

Bullboard Posts

Next >>

Comment by DeathXray33on Oct 24, 2024 10:21am

138 Views

Post# 36280142

RE:RE:RE:GL All

zombize wrote: I bought at the same time because for no other reason than it was an exciting story. I've since had 3 family members die of cancer, and I've often wondered how this technology could have helped. Looking forward to this actually hitting the market and saving lives. Cheers.

"When cervical cancer is diagnosed after it has spread to a distant part of the body, the 5-year relative survival rate is 19%."

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages